LION's strategy to move towards the informatics sector, shifting
the focus away from the drug development sector seems to be gaining
momentum as second quarter net losses were reduced to €3.4million
compared to €6.5 million in...
Germany's LION bioscience has made a foray into the market for
cheminformatics software with a new package designed to help
pharmaceutical companies identify, select and priortise compounds,
based on data emerging from the medicinal...
Germany'sLion Bioscience has reported a slight financial
improvement from a year ago, trimming losses in the first quarter.
53 per cent of the Lion's Q1 revenues, or €2.1 million were
generated from Bayer projects.